Mirai Bio is a Biotech company. It has raised $120M in total funding. Latest round: Series A. Backed by Flagship Pioneering.
Mirai Bio funding overview
Mirai Bio is a Biotech company. Mirai Bio has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Mirai Bio runs through 2024; nothing later has been disclosed. Investors on record include Flagship Pioneering.
Mirai Bio at a glance
Total raised
$120M
Latest round
Series A
Latest round date
September 2024
Industry
Biotech
Notable investors
Flagship Pioneering
Frequently asked about Mirai Bio funding
How much has Mirai Bio raised?
Mirai Bio has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Mirai Bio?
Flagship Pioneering are named among the investors backing Mirai Bio.
What was the latest Mirai Bio funding round?
The most recent disclosed round is a Series A, announced in September 2024.
Where is Mirai Bio based?
No headquarters location is disclosed for Mirai Bio.
What sector does Mirai Bio operate in?
Mirai Bio is tracked under Biotech, with $120M in disclosed funding.
When did Mirai Bio last raise?
The last disclosed Mirai Bio round closed in September 2024 at Series A.
We update the Mirai Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
